Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

Share Price is delayed by 15 minutes
Get Live Data
50.80    -0.20 (-0.39%)
Bid:
49.95
Ask:
50.30
Spread: 0.35 (0.701%)
Market Cap: £670.89m
IQE Live PriceLast checked at - London Stock Exchange

Intraday IQE Share Chart

Trading Update and comment on US Entity List

24 May 2019 07:00



Trading Update and comment on US Entity List

IQE plc

Cardiff, UK. 24th May 2019: IQE plc (AIM: IQE; "IQE", the “Company” or the "Group"), the leading global supplier of advanced wafer products and materials solutions to the semiconductor industry, provides the following trading update in response to action taken by the Bureau of Industry and Security (BIS) of the United States Department of Commerce to add Huawei Technologies Co., Ltd. and 68 of its affiliates (“Huawei”) to the “Entity List” maintained by the Department. The BIS action prohibits the sale to Huawei, by certain of IQE’s customers, of products covered by the Export Administration Regulations (EAR) absent obtaining an appropriate export license.

IQE wishes to clarify its potential exposure to this rapidly evolving situation, as it supplies epitaxial wafers to multiple chip companies in global supply chains, some of whom supply Huawei.

The situation involving the ban is dynamic and it is not clear at this time how long it will remain in force or what the full implications will be. However, IQE believes it is in a strong position to adjust to the possible consequences and scenarios resulting from this in a positive manner. Across all product lines, IQE has supply relationships with multiple non-US customers, so is well placed to adapt to mid to long-term share shifts at both the component (chip) and the OEM level. The majority of IQE’s technologies and supply chains are not affected by the ban and IQE complies fully with the EAR.

In the short-term, IQE believes it may experience some delay to orders and the potential for adjustment of supplier managed inventory levels, predominantly in its Wireless Business Unit. The Photonics and Infrared Business Units are essentially unaffected.

The company has been engaging across its customer base in recent days specifically on this subject and estimates that its current maximum risk exposure to this matter is less than 5% of total FY 2019 revenue guidance.

Although there remains uncertainty and unpredictability related to this specific matter, given the market opportunity IQE faces in H2, the company leaves full year guidance unchanged.

Dr Drew Nelson, Chief Executive of IQE, said:

‘The recent ban on sales of products from US companies to Huawei and its affiliates is a factor completely outside of IQE’s control. However, our long-term strategy of supplying as many of the supply chains into all major OEMs as possible, protects IQEs overall supply to a very significant degree. As a result, we believe the ban will have a limited impact on our mid to long term revenue trajectory. Indeed, the breadth of IQE’s current product range, the new materials technologies being introduced to market over the coming months and years, and IQE’s global manufacturing footprint are powerful mitigating factors in dealing effectively with the ongoing changing geopolitical landscape in our industry."

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

CONTACTS:

  
  
  

IQE plc +44 (0) 29 2083 9400Tim PullenDrew NelsonChris Meadows Canaccord Genuity (Nomad and Joint Broker) + 44 (0) 20 7523 8000Simon BridgesRichard Andrews

Peel Hunt (Joint Broker) +44 (0) 20 7418 8900Edward KnightNick Prowting

ABOUT IQE

http://iqep.com IQE is the leading global supplier of advanced semiconductor wafers that enable a diverse range of applications, supported by an innovative outsourced foundry services portfolio that allows the Group to provide a 'one stop shop' for the wafer needs of the world's leading semiconductor manufacturers. IQE uses advanced crystal growth technology (epitaxy) to manufacture and supply bespoke semiconductor wafers 'epi-wafers' to the major chip manufacturing companies, who then use these wafers to make the chips which form the key components of virtually all high technology systems. IQE is unique in being able to supply wafers using all of the leading crystal growth technology platforms. IQE's products are found in many leading-edge consumer, communication, computing and industrial applications, including a complete range of wafer products for the wireless industry, such as smartphones and wireless infrastructure, Wi-Fi, base stations, and satellite communications; optical communications, optical storage, printing, thermal imagers, leading-edge medical technologies, automotive and aerospace technologies, a variety of advanced silicon based systems and high efficiency concentrator photovoltaic (CPV) solar cells. IQE is headquartered in Cardiff UK and operates multiple manufacturing and R&D facilities worldwide.


Date   Source Headline
6th Nov 202011:00 amGNWHolding(s) in Company
2nd Nov 20208:00 amGNWIQE plc: Total voting rights
2nd Nov 20207:00 amRNSIQE plc: Development of IQGeVCSEL 150™ technology
29th Oct 20204:00 pmGNWIQE plc: Holding(s) in Company
29th Oct 20202:07 pmRNSIQE plc: Dr D Nelson awarded IoP Gold Medal
5th Oct 20207:00 amGNWIQE plc: Acquisition of minority interests in IQE Taiwan Corporation
30th Sep 20204:00 pmGNWIQE plc: Total voting rights
8th Sep 20207:00 amGNWIQE plc: 2020 Interim Results
1st Sep 20207:00 amGNWTotal voting rights
5th Aug 20204:00 pmGNWIQE plc: Holding(s) in Company
31st Jul 20204:00 pmGNWIQE plc: Total voting rights and Director Shareholding
6th Jul 20204:00 pmGNWIQE plc: Holding(s) in Company
30th Jun 202012:00 pmGNWIQE plc: Total voting rights and Block Admission Return
29th Jun 20202:25 pmGNWIQE plc: Result of AGM
26th Jun 20207:04 amRNSIQE plc: SIPF funding of South Wales cluster
23rd Jun 20204:00 pmGNWIQE plc: Holding(s) in Company
16th Jun 20204:00 pmGNWIQE plc: Holding(s) in Company
12th Jun 20207:00 amGNWIQE plc: Trading Statement
10th Jun 20204:00 pmGNWIQE plc: Holding(s) in Company
29th May 20207:00 amRNSIQE plc: Notice of AGM
12th May 20204:00 pmGNWIQE plc: Holding(s) in Company
11th May 20207:00 amGNWIQE plc: Director/PDMR Shareholding
6th May 20207:00 amRNSIQE wins BAE Systems' Gold Tier Award
30th Apr 20204:00 pmGNWIQE plc: Total voting rights
28th Apr 20207:00 amGNWIQE plc: 2019 Full Year Results
28th Apr 20207:00 amGNWIQE plc: 2019 Full Year Results
24th Apr 20204:00 pmGNWIQE plc: Notice of Results
14th Apr 202012:00 pmGNWIQE plc: Holding(s) in Company
31st Mar 20204:00 pmGNWIQE plc: Total voting rights
24th Mar 20207:00 amGNWIQE plc: Trading Update
23rd Mar 20203:50 pmGNWIQE plc: Delay to Full Year 2019 Results
20th Mar 20204:00 pmGNWIQE plc: Holding(s) in Company
20th Mar 202012:00 pmGNWIQE plc: Holding(s) in Company
18th Mar 202012:00 pmGNWIQE plc: Holding(s) in Company
16th Mar 202012:00 pmGNWIQE plc: Holding(s) in Company
5th Mar 202012:00 pmGNWIQE plc: Holding(s) in Company
28th Feb 202012:00 pmGNWIQE plc: Total voting rights
21st Feb 20207:00 amGNWIQE plc: Long Term Incentive Plan (LTIP) Awards
14th Feb 20203:00 pmGNWIQE plc: Holding(s) in Company
6th Feb 20203:00 pmGNWIQE plc: Holding(s) in Company
6th Feb 20203:00 pmGNWIQE plc: Holding(s) in Company
5th Feb 20201:34 pmGNWIQE plc: Holding(s) in Company
31st Jan 202012:00 pmGNWIQE plc: Total voting rights
22nd Jan 202011:00 amGNWIQE plc: Holding(s) in Company
21st Jan 20203:00 pmGNWBlock Admission Application and Block Admission Return
31st Dec 201912:00 pmGNWTotal voting rights
24th Dec 20197:00 amGNW2019 AGM LTIP resolution voting and proposed actions
17th Dec 201912:00 pmGNWIQE plc: Holding(s) in Company
27th Nov 20194:00 pmGNWHolding(s) in Company
27th Nov 20194:00 pmGNWHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.